JY
Insider
Jonathan Young
Chief Operating OfficerJonathan Young (Chief Operating Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AKRO. The largest single filing was $597K of AKRO (12,500 sh across 2 lots, as filed), executed Oct 1 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$597K
shares × price, as filed
Last traded
Oct 1 2025
Filed Oct 3 2025
Volume by month
Buys $0
Sells $8.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AKRO
AKRO
AKRO · 0 buys · 11 sells
11 filings
Recent filings
AKROSALE
Akero Therapeutics, Inc.
View filing →
$1.6M50,424 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $1.2M
40,000 sh × $30.15
Exec Oct 14 2024
Filed Oct 16 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $282K
10,000 sh × $28.18
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET